Alerts will be sent to your verified email
Verify Email
SANOFI
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Sanofi India Limited sells a wide range of medications and dietary supplements for the treatment of various diseases in India. The company primarily operates through independent distributors.
Sanofi India major competitors are Procter&Gamble Healt, Natco Pharma, Strides Pharma Scien, Caplin Point Lab, Marksans Pharma, FDC, Jubilant Pharmova.
Market Cap of Sanofi India is ₹11,786 Crs.
While the median market cap of its peers are ₹10,479 Crs.
Sanofi India seems to be less financially stable compared to its competitors.
Altman Z score of Sanofi India is 2.92 and is ranked 8 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Jun Sep | |||||||||||||||||
| Investor Presentation | Mar | Mar Sep Dec | Dec | Dec | ||||||||||||||
| Conference Call | Mar | Mar Sep Dec | Dec | |||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
